Steve Crow
About Steve Crow
Steve Crow serves as the Director of Client Solutions at ConnectiveRx, where he has worked since 2011. He has extensive experience in marketing communications within the healthcare sector, having previously held positions at Publicis Touchpoint Solutions and Publicis Healthcare Communications Group.
Work at ConnectiveRx
Steve Crow has served as the Director of Client Solutions at ConnectiveRx since 2011. In this role, he oversees client engagement and develops strategies to enhance service delivery. His extensive experience in marketing communications and client solutions contributes to the company's focus on improving patient access to medications and optimizing healthcare outcomes.
Previous Experience in Marketing Communications
Before joining ConnectiveRx, Steve Crow worked at Publicis Touchpoint Solutions from 2009 to 2018 as a Marketing Communications professional. His role involved developing marketing strategies and communications that supported client objectives. Prior to that, he was the Director of Professional Communication at Publicis Healthcare Communications Group from 2003 to 2009, where he managed communication initiatives in the healthcare sector.
Education and Expertise
Steve Crow holds a Bachelor of Science in Business Administration from Fort Hays State University, where he studied from 1974 to 1978. He also earned a Master of Science in Technical Writing from Utah State University. Additionally, he is certified in Business-to-Business Marketing by the Business Marketing Institute and is a Board-certified Editor in the Life Sciences (ELS).
Achievements in the Biopharma Industry
Steve Crow has made significant contributions to the biopharma industry, particularly from 2008 to 2010, when he spurred double-digit growth through strategic marketing initiatives. He has conducted hundreds of live group discussions with healthcare professionals, enhancing communication and understanding within the industry. He also created and managed comprehensive marketing communications plans that supported the largest contract sales organization in the biopharma sector.